Co‐delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Controlled Release

• Publication date

  2018-04-10

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.jconrel.2018.02.026PMID 29471038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancing Doxorubicin Delivery toward Tumor by Hydroxyethyl Starch-g-Polylactide Partner Nanocarriers.

  2017cited by this paper
• Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

  2017cited by this paper
• Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer.

  2017cited by this paper
• α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.

  2017cited by this paper
• Targeting epithelial-mesenchymal transition: Metal organic network nano-complexes for preventing tumor metastasis.

  2017cited by this paper
• Drug Delivery Systems Based on Hydroxyethyl Starch.

  2017cited by this paper
• Efficient extravasation of tumor-repopulating cells depends on cell deformability

  2016cited by this paper
• Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail

  2016cited by this paper
• Drug binding rate regulates the properties of polysaccharide prodrugs.

  2016cited by this paper
• To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

  2016cited by this paper
• Domino-Like Intercellular Delivery of Undecylenic Acid-Conjugated Porous Silicon Nanoparticles for Deep Tumor Penetration.

  2016cited by this paper
• EMT: 2016.

  2016cited by this paper
• The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells

  2016cited by this paper
• Analysis of nanoparticle delivery to tumours

  2016cited by this paper
• Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.

  2016cited by this paper
• AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.

  2015cited by this paper
• Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells

  2015cited by this paper
• The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment.

  2015cited by this paper
• Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy

  2014cited by this paper
• Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

  2014cited by this paper
• Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

  2014cited by this paper
• The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes.

  2013cited by this paper
• Strategies for advancing cancer nanomedicine.

  2013cited by this paper
• The roles of TGFβ in the tumour microenvironment

  2013cited by this paper
• Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response.

  2013cited by this paper
• Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model

  2013cited by this paper
• TGF-β: An emerging player in drug resistance

  2013cited by this paper
• TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.

  2013cited by this paper
• Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

  2013cited by this paper
• Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice.

  2013cited by this paper
• Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase.

  2012cited by this paper
• Exploiting the protein corona around gold nanorods for loading and triggered release.

  2012cited by this paper
• A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.

  2011cited by this paper
• Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Antimetastatic role of Smad4 signaling in colorectal cancer.

  2010cited by this paper
• Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

  2010cited by this paper
• Delivering nanomedicine to solid tumors

  2010cited by this paper
• Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer.

  2009cited by this paper
• Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells

  2009cited by this paper
• Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice.

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Blocking transforming growth factor–beta up‐regulates E‐cadherin and reduces migration and invasion of hepatocellular carcinoma cells

  2008cited by this paper
• Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

  2007cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• High-resolution imaging of the dynamic tumor cell–vascular interface in transparent zebrafish

  2007cited by this paper
• Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

  2007cited by this paper
• The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer.

  2007cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Repopulation of cancer cells during therapy: an important cause of treatment failure

  2005cited by this paper
• The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors

  2005cited by this paper
• Pharmacokinetics of Pegylated Liposomal Doxorubicin

  2003cited by this paper
• Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

  2002cited by this paper
• Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.

  2002cited by this paper
• The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis.

  2002cited by this paper
• Doxorubicin gradients in human breast cancer.

  1999cited by this paper
• An international view of hydroxyethyl starches

  1999cited by this paper
• Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.

  1998cited by this paper
• Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

  1988cited by this paper

• Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment

  2026cites this paper
• Progress on hydroxyethyl starch-based smart nanomedicines

  2025cites this paper
• Zebrafish as a versatile preclinical model for evaluating nanomedicine in biomedical research: Recent advances and applications

  2025cites this paper
• Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma.

  2024cites this paper
• ROS-Responsive and Self-Catalytic Nanocarriers for a Combination of Chemotherapy and Reinforced Ferroptosis against Breast Cancer.

  2024cites this paper
• Indocyanine green-mediated fabrication of urchin-like hydroxyethyl starch nanocarriers for enhanced drug tumor EPR and deep penetration effects.

  2024cites this paper
• Nanoparticles for Augmenting Therapeutic Potential and Alleviating the Effect of Di(2-ethylhexyl) Phthalate on Gastric Cancer

  2024cites this paper
• Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments

  2024cites this paper
• Nanomedicine Tumor Targeting

  2024cites this paper
• Personalized nanovaccines for treating solid cancer metastases

  2024cites this paper
• Boosting Oxidative Stress with Hydroxyethyl Starch Smart Nanomedicines to Eliminate Cancer Stem Cells

  2024cites this paper
• Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.

  2023cites this paper
• Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT).

  2023cites this paper
• Reductive lipid nanoparticles loaded with vinorelbine inhibit chemotherapy-induced invasion of cancer cells by modulating ENPP2

  2023cites this paper
• Gold Nanoparticles Inhibit Extravasation of Canine Osteosarcoma Cells in the Ex Ovo Chicken Embryo Chorioallantoic Membrane Model

  2023cites this paper
• MBD2 facilitates tumor metastasis by mitigating DDB2 expression

  2023cites this paper
• TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cells.

  2023cites this paper
• Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy.

  2023cites this paper
• Targeting cancer-associated fibroblasts with hydroxyethyl starch nanomedicine boosts cancer therapy

  2023cites this paper
• A pHe sensitive nanodrug for collaborative penetration and inhibition of metastatic tumors.

  2022cites this paper
• A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages.

  2022cites this paper
• Tumor-oriented mathematical models in hydrogel regulation for precise topical administration regimens.

  2022cites this paper
• What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine

  2022cites this paper
• Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis

  2022cites this paper
• Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment

  2022cites this paper
• Precise fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based smart nanomedicine for enhanced antitumor efficacy.

  2022cites this paper
• Potential of Alpha-Mangostin-Loaded PLGA Nanoparticles for Cholangiocarcinoma Treatment

  2022cites this paper
• Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.

  2022cites this paper
• Nanoengineered drug delivery in cancer immunotherapy for overcoming immunosuppressive tumor microenvironment

  2022cites this paper
• Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis

  2021cites this paper
• A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase.

  2021cites this paper
• Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy

  2021cites this paper
• Redox-sensitive hyaluronic acid-cholesterol nanovehicles potentiate efficient Transmembrane internalization and controlled release for penetrated "full-line" inhibition of pre-metastatic initiation.

  2021cites this paper
• Hydroxyethyl starch based smart nanomedicine

  2021cites this paper
• Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between “seed and soil”

  2021cites this paper
• The past, present, and future of breast cancer models for nanomedicine development

  2021cites this paper
• Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer

  2021cites this paper
• Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis.

  2021cites this paper
• Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

  2021cites this paper
• Update on the development of molecular imaging and nanomedicine in China: Optical imaging.

  2020cites this paper
• High Intensity Focused Ultrasound-Responsive and Ultrastable Cerasomal Perfluorocarbon Nanodroplets for Alleviating Tumor Multidrug Resistance and Epithelial-Mesenchymal Transition.

  2020cites this paper
• A pH‐responsive polymer linked with immunomodulatory drugs: synthesis, characteristics and in vitro biocompatibility

  2020cites this paper
• Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges

  2020cites this paper
• Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy.

  2020cites this paper
• Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers

  2020cites this paper
• A Perspective on Polylactic Acid-Based Polymers Use for Nanoparticles Synthesis and Applications

  2019cites this paper
• Receptors for Targeting Growth Factors for Treatment of Cancers

  2019cites this paper
• Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery

  2019cites this paper
• Dual stimuli-guided lipid-based delivery system of cancer combination therapy.

  2019cites this paper
• Zebrafish as a preclinical in vivo screening model for nanomedicines.

  2019cites this paper
• Transformable nanotherapeutics enabled by ICG: towards enhanced tumor penetration under NIR light irradiation.

  2019cites this paper
• A Simple Glutathione-Responsive Turn-on Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy.

  2019cites this paper
• Creation of polylactide vascular scaffolds with high compressive strength using a novel melt-tube drawing method

  2019cites this paper
• Artificial intelligence in nanomedicine.

  2019cites this paper
• A switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis.

  2019cites this paper
• iRGD-decorated reduction-responsive nanoclusters for targeted drug delivery.

  2018cites this paper
• BCL6 promotes the methotrexate-resistance by upregulating ZEB1 expression in children with acute B lymphocytic leukemia.

  2018cites this paper
• Colloidal hydroxyethyl starch for tumor-targeted platinum delivery

  2018cites this paper